Rather than conducting a new meta-analysis, the authors synthesize findings from major randomized clinical trials, highlighting outcomes related to glycated hemoglobin (HbA1c), body weight reduction, major adverse cardiovascular events (MACE), and kidney function decline as reported in large cardiovascular outcomes trials (CVOTs), obesity randomized controlled trials, and early-phase clinical development studies
Providers adjust plans over time based on ongoing progress
Athletes subject to anti-doping testing should be aware that these compounds may be detectable and could result in sanctions
Additionally, the medication's effects on gut motility and the gastrointestinal microenvironment have not been extensively studied in the context of active intestinal inflammation
Disclaimer All information in this article is provided for educational purposes and describes findings from in vitro, rodent and other preclinical research literature, along with a neutral summary of anecdotal community sentiment